FDA Approves Photrexa for Corneal Crosslinking in Keratoconus

The riboflavin ophthalmic solution, once irradiated with ultraviolet A light, treats sight-threatening keratoconus with corneal collagen crosslinking.
FDA Approvals

Full Story →